Skip to main content
. 2022 May 9;14(5):e24845. doi: 10.7759/cureus.24845

Table 2. Demographic and clinical profile of the included cases (N=50).

Variable n (%)
Male 24 (52.0)
Female 26 (48.0)
Age (years), mean ± standard deviation (range) 33.6±16.8 (2-78)
Disease duration (days), median (range) 75 (2-5475)
First episode 26 (52.0)
One or more episodes in the past 24 (48.0)
      Symptoms Itching 26 (52.0)
Pain at lesional site/ burning sensation 16 (32.0)
Fever 15 (30.0)
Myalgia 5 (10.0)
Arthralgia 21 (42.0)
Gastrointestinal symptoms 7 (14.0)
Distribution of the skin lesions   Lower limbs 12 (24.0)
Lower limbs, upper limbs and, or trunk 30 (60.0)  
Generalized (including face) 8 (16.0)
Cutaneous morphology   Palpable purpura 28 (56.0)
Purpuric macule 2 (4.0)
Erythematous maculopapular rash 1 (2.0)
Urticated plaque/ papule 23 (46.0)
Annular urticated plaque 8 (16.0)
Vesicles/ bullae 6 (12.0)
Surface ulceration/ crusting 4 (8.0)
Cutaneous necrosis 8 (16.0)
Retiform purpura 4 (8.0)
Pustule 2 (4.0)
General examination   Lymphadenopathy 3 (6.0)
Pallor 17 (34.0)
Edema of hand and feet 22 (44.0)
Systemic examination Arthritis (Joint swelling/ tenderness)   11 (22.0)
Laboratory abnormalities   Anemia 10 (20.0)
Leucocytosis 5 (10.0)
Leucopenia 8 (16.0)
Elevated erythrocyte sedimentation rate 34 (68.0)  
Elevated C-reactive protein 6 (12.0)
Deranged liver function test 4 (8.0)
Elevated creatinine 3 (6.0)
ANA positive 3 (6.0)
Hematuria 2 (4.0)
Glucosuria 2 (4.0)
Proteinuria 3 (6.0)
Occult blood in stool 4 (8.0)